Peptide Library

FDA-approved

Digestive & weight

Enlicitide

Evidence

FDA approved

Class

Oral macrocyclic PCSK9 inhibitor peptide

/

Enlicitide

KEY TAKEAWAY

Enlicitide is an oral macrocyclic peptide designed to block PCSK9, a protein that reduces the liver's ability to clear LDL cholesterol. It is sold as Lipfendra. The FDA approved enlicitide (Lipfendra) in July 2026 as the first oral PCSK9 inhibitor, for adults with high cholesterol alongside diet and exercise.

Written by the Veylo editorial team · Updated

November 2026

At a glance

At a glance

What it is

Oral macrocyclic PCSK9 inhibitor peptide

Approved for

High LDL cholesterol, including heterozygous familial hypercholesterolemia

Key fact

The FDA approved enlicitide (Lipfendra) in July 2026 as the first oral PCSK9 inhibitor, for adults with high cholesterol alongside diet and exercise.

Route

One 20 mg tablet once a day

Evidence strength

FDA approved

What it is

What it is

Enlicitide is an oral macrocyclic peptide designed to block PCSK9, a protein that reduces the liver's ability to clear LDL cholesterol. It is sold as Lipfendra.

How it works

How it works

By blocking PCSK9, it leaves more LDL receptors on liver cells to pull LDL cholesterol out of the blood.

Regulatory status

Regulatory status

The FDA approved enlicitide (Lipfendra) in July 2026 as the first oral PCSK9 inhibitor, for adults with high cholesterol alongside diet and exercise.

What it is used for

What it is used for

High LDL cholesterol, including heterozygous familial hypercholesterolemia.

Side effects and risks

Side effects and risks

In one pivotal trial diarrhea and dizziness were more common with enlicitide than with placebo. Data on heart attacks and strokes are still awaited.

Citations

Citations

U.S. FDA prescribing information for Enlicitide. DailyMed, National Library of Medicine.

Veylo content is educational and not medical advice. Peptides that are not FDA-approved are not approved for the uses described.

Veylo

Clinician-guided peptide care, paired with baseline blood testing and ongoing support.

Peptides referenced on this site are compounded medications and are investigational; they have not been approved by the FDA for the uses described. Nothing here is medical advice. Prescriptions are issued only after a licensed clinician reviews your history.

© 2026 Veylo. All rights reserved.

Veylo

Veylo

Veylo